Letter: Nitrofurantoin-induced pulmonary fibrosis and lupus syndrome.
D000918:Antibody Specificity; D001323:Autoantibodies / Q000302:isolation & purification*; D005260:Female; D006801:Humans; D007136:Immunoglobulins / Q000302:isolation & purification; D008180:Lupus Erythematosus, Systemic / Q000139:chemically induced; D008213:Lymphocyte Activation / Q000187:drug effects; D009582:Nitrofurantoin / Q000009:adverse effects* / Q000494:pharmacology; D011658:Pulmonary Fibrosis / Q000097:blood / Q000139:chemically induced* / Q000150:complications / Q000276:immunology; D013577:Syndrome
D001323:Autoantibodies; D007136:Immunoglobulins; D009582:Nitrofurantoin